{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:09:40Z","timestamp":1778584180470,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41470-x","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:03:06Z","timestamp":1773932586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of phytochemicals from Tamarindus indica as a potential catechol-O-methyltransferase (COMT) inhibitor: an in-silico approach for Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Aparna G.","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashin","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyan","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowtham","family":"Nirmal Jonnalagadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Raish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyas","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"41470_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. V. Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management. Lancet Neurol. 5, 235\u2013245. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8 (2006).","journal-title":"Lancet Neurol."},{"key":"41470_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"41470_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/neuroglia5040030","volume":"5","author":"I Viveros-Mart\u00ednez","year":"2024","unstructured":"Viveros-Mart\u00ednez, I. et al. Characterizing secondary and atypical Parkinsonisms: Defining features and clinical variability. Neuroglia 5, 467\u2013487 (2024).","journal-title":"Neuroglia"},{"key":"41470_CR4","unstructured":"National Institute of Neurological, D. & Stroke. Parkinson\u2019s Disease. (2024)."},{"key":"41470_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","volume":"184","author":"Y Zhuang","year":"2021","unstructured":"Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931-942 e918. https:\/\/doi.org\/10.1016\/j.cell.2021.01.027 (2021).","journal-title":"Cell"},{"key":"41470_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9730467","volume":"2016","author":"H Juarez Olguin","year":"2016","unstructured":"Juarez Olguin, H., Calderon Guzman, D., Hernandez Garcia, E. & Barragan Mejia, G. The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid. Med. Cell. Longev. 2016, 9730467. https:\/\/doi.org\/10.1155\/2016\/9730467 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"41470_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu, J. M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182\u2013217. https:\/\/doi.org\/10.1124\/pr.110.002642 (2011).","journal-title":"Pharmacol. Rev."},{"key":"41470_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","volume":"16","author":"N Tambasco","year":"2018","unstructured":"Tambasco, N., Romoli, M. & Calabresi, P. Levodopa in Parkinson\u2019s disease: Current status and future developments. Curr. Neuropharmacol. 16, 1239\u20131252. https:\/\/doi.org\/10.2174\/1570159X15666170510143821 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"41470_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03843-1","volume":"14","author":"F Zumaila","year":"2024","unstructured":"Zumaila, F., Jeevalatha, A. & Biju, C. N. Genetic diversity, mating type and pathogenicity of two Phytophthora species infecting black pepper in India. 3 Biotech 14, 1. https:\/\/doi.org\/10.1007\/s13205-023-03843-1 (2024).","journal-title":"3 Biotech"},{"key":"41470_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2008.02.069","volume":"34","author":"M K\u00e4enm\u00e4ki","year":"2008","unstructured":"K\u00e4enm\u00e4ki, M., Tammim\u00e4ki, A. & M\u00e4nnist\u00f6, P. T. Importance of the two forms of catechol-O-methyltransferase (COMT) in l-dopa metabolism: A pharmacokinetic study in COMT knock-out mice and in mice lacking soluble COMT. Eur. J. Pharm. Sci. 34, S28. https:\/\/doi.org\/10.1016\/j.ejps.2008.02.069 (2008).","journal-title":"Eur. J. Pharm. Sci."},{"key":"41470_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11030-020-10053-x","volume":"25","author":"J de Beer","year":"2021","unstructured":"de Beer, J., Petzer, J. P., Lourens, A. C. U. & Petzer, A. Design, synthesis and evaluation of 3-hydroxypyridin-4-ones as inhibitors of catechol-O-methyltransferase. Mol. Divers. 25, 753\u2013762. https:\/\/doi.org\/10.1007\/s11030-020-10053-x (2021).","journal-title":"Mol. Divers."},{"issue":"4","key":"41470_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1124\/mol.62.4.795","volume":"62","author":"MJ Bonifacio","year":"2002","unstructured":"Bonifacio, M. J. et al. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application. Mol. Pharmacol. 62(4), 795\u2013805. https:\/\/doi.org\/10.1124\/mol.62.4.795 (2002).","journal-title":"Mol. Pharmacol."},{"key":"41470_CR13","doi-asserted-by":"publisher","DOI":"10.5808\/gi.20061","volume":"19","author":"SN Rath","year":"2021","unstructured":"Rath, S. N., Jena, L., Bhuyan, R., Mahanandia, N. C. & Patri, M. In silico discovery and evaluation of phytochemicals binding mechanism against human catechol-O-methyltransferase as a putative bioenhancer of L-DOPA therapy in Parkinson disease. Genomics Inform. 19, e7. https:\/\/doi.org\/10.5808\/gi.20061 (2021).","journal-title":"Genomics Inform."},{"key":"41470_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jmb.2008.04.040","volume":"380","author":"K Rutherford","year":"2008","unstructured":"Rutherford, K., Le Trong, I., Stenkamp, R. E. & Parson, W. W. Crystal structures of human 108V and 108M catechol O-methyltransferase. J. Mol. Biol. 380, 120\u2013130. https:\/\/doi.org\/10.1016\/j.jmb.2008.04.040 (2008).","journal-title":"J. Mol. Biol."},{"key":"41470_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18926\/AMO\/31725","volume":"56","author":"CH Tai","year":"2002","unstructured":"Tai, C. H. & Wu, R. M. Catechol-O-methyltransferase and Parkinson\u2019s disease. Acta Med. Okayama. 56, 1\u20136. https:\/\/doi.org\/10.18926\/AMO\/31725 (2002).","journal-title":"Acta Med. Okayama."},{"key":"41470_CR16","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.3390\/ijms25137183","volume":"25","author":"M Muleiro Alvarez","year":"2024","unstructured":"Muleiro Alvarez, M. et al. A comprehensive approach to Parkinson\u2019s disease: Addressing its molecular, clinical, and therapeutic aspects. Int. J. Mol. Sci. 25, 7183 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"41470_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12264-017-0178-2","volume":"33","author":"S Li","year":"2017","unstructured":"Li, S. & Le, W. Milestones of Parkinson\u2019s disease research: 200 years of history and beyond. Neurosci. Bull. 33, 598\u2013602. https:\/\/doi.org\/10.1007\/s12264-017-0178-2 (2017).","journal-title":"Neurosci. Bull."},{"key":"41470_CR18","doi-asserted-by":"publisher","unstructured":"Entacapone improves motor fluctuations in levodopa-treated Parkinson\u2019s disease patients. Parkinson Study Group. Ann. Neurol. 42, 747\u2013755. https:\/\/doi.org\/10.1002\/ana.410420511 (1997).","DOI":"10.1002\/ana.410420511"},{"key":"41470_CR19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1212\/wnl.51.5.1309","volume":"51","author":"UK Rinne","year":"1998","unstructured":"Rinne, U. K., Larsen, J. P., Siden, A. & Worm-Petersen, J. Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Nomecomt Study Group. Neurology 51, 1309\u20131314. https:\/\/doi.org\/10.1212\/wnl.51.5.1309 (1998).","journal-title":"Neurology"},{"key":"41470_CR20","unstructured":"Muranova, A. & Shanina, E. In StatPearls (2025)."},{"key":"41470_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/archneur.61.10.1563","volume":"61","author":"CW Olanow","year":"2004","unstructured":"Olanow, C. W. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Arch. Neurol. 61, 1563\u20131568. https:\/\/doi.org\/10.1001\/archneur.61.10.1563 (2004).","journal-title":"Arch. Neurol."},{"key":"41470_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00702-023-02692-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer, P. & Horowski, R. L-DOPA-therapy in Parkinson\u2019s disease: Some personal reflections on L-DOPA therapy from Vienna and Berlin. J. Neural Transm. 130, 1323\u20131335. https:\/\/doi.org\/10.1007\/s00702-023-02692-9 (2023).","journal-title":"J. Neural Transm."},{"key":"41470_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17460441.2020.1691165","volume":"15","author":"K Moschovou","year":"2020","unstructured":"Moschovou, K., Melagraki, G., Mavromoustakos, T., Zacharia, L. C. & Afantitis, A. Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson\u2019s disease therapeutics. Expert Opin. Drug Discov. 15, 53\u201362. https:\/\/doi.org\/10.1080\/17460441.2020.1691165 (2020).","journal-title":"Expert Opin. Drug Discov."},{"key":"41470_CR24","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1107\/S1399004714012917","volume":"70","author":"A Ehler","year":"2014","unstructured":"Ehler, A., Benz, J., Schlatter, D. & Rudolph, M. G. Mapping the conformational space accessible to catechol-O-methyltransferase. Acta Crystallogr. D Biol. Crystallogr. 70, 2163\u20132174. https:\/\/doi.org\/10.1107\/S1399004714012917 (2014).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"41470_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1107\/S1744309104031197","volume":"61","author":"ML Rodrigues","year":"2005","unstructured":"Rodrigues, M. L., Bonifacio, M. J., Soares-da-Silva, P., Carrondo, M. A. & Archer, M. Crystallization and preliminary X-ray diffraction studies of a catechol-O-methyltransferase\/inhibitor complex. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61, 118\u2013120. https:\/\/doi.org\/10.1107\/S1744309104031197 (2005).","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"41470_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/s0149-2918(01)80071-0","volume":"23","author":"J Najib","year":"2001","unstructured":"Najib, J. Entacapone: A catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson\u2019s disease. Clin. Ther. 23, 802\u2013832. https:\/\/doi.org\/10.1016\/s0149-2918(01)80071-0 (2001) (discussion 771).","journal-title":"Clin. Ther."},{"key":"41470_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2165\/00003495-200059060-00004","volume":"59","author":"S Kaakkola","year":"2000","unstructured":"Kaakkola, S. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson\u2019s disease. Drugs 59, 1233\u20131250. https:\/\/doi.org\/10.2165\/00003495-200059060-00004 (2000).","journal-title":"Drugs"},{"key":"41470_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mdc3.13094","volume":"7","author":"P Vokurka","year":"2020","unstructured":"Vokurka, P. et al. Opicapone efficacy and tolerability in Parkinson\u2019s disease patients reporting insufficient benefit\/failure of Entacapone. Mov. Disord. Clin. Pract. 7, 955\u2013960. https:\/\/doi.org\/10.1002\/mdc3.13094 (2020).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"41470_CR29","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1021\/acscatal.9b00174","volume":"9","author":"S Czarnota","year":"2019","unstructured":"Czarnota, S. et al. Equatorial active site compaction and electrostatic reorganization in catechol-O-methyltransferase. ACS Catal. 9, 4394\u20134401. https:\/\/doi.org\/10.1021\/acscatal.9b00174 (2019).","journal-title":"ACS Catal."},{"key":"41470_CR30","doi-asserted-by":"publisher","first-page":"9092","DOI":"10.1002\/anie.200904410","volume":"48","author":"M Ellermann","year":"2009","unstructured":"Ellermann, M. et al. Molecular recognition at the active site of catechol-O-methyltransferase: Energetically favorable replacement of a water molecule imported by a bisubstrate inhibitor. Angew. Chem. Int. Ed. Engl. 48, 9092\u20139096. https:\/\/doi.org\/10.1002\/anie.200904410 (2009).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"41470_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1042\/BST20060330","volume":"34","author":"WA Loenen","year":"2006","unstructured":"Loenen, W. A. S-adenosylmethionine: Jack of all trades and master of everything?. Biochem. Soc. Trans. 34, 330\u2013333. https:\/\/doi.org\/10.1042\/BST20060330 (2006).","journal-title":"Biochem. Soc. Trans."},{"key":"41470_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bcp.12169","volume":"77","author":"Z Ma","year":"2014","unstructured":"Ma, Z., Liu, H. & Wu, B. Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders. Br. J. Clin. Pharmacol. 77, 410\u2013420. https:\/\/doi.org\/10.1111\/bcp.12169 (2014).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"41470_CR33","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1039\/d2ra01340a","volume":"12","author":"AH Elmaidomy","year":"2022","unstructured":"Elmaidomy, A. H. et al. The anti-Alzheimer potential of Tamarindus indica: An in vivo investigation supported by in vitro and in silico approaches. RSC Adv. 12, 11769\u201311785. https:\/\/doi.org\/10.1039\/d2ra01340a (2022).","journal-title":"RSC Adv."},{"key":"41470_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070058","volume":"8","author":"CY Lim","year":"2013","unstructured":"Lim, C. Y., Mat Junit, S., Abdulla, M. A. & Abdul Aziz, A. In vivo biochemical and gene expression analyses of the antioxidant activities and hypocholesterolaemic properties of Tamarindus indica fruit pulp extract. PLoS ONE 8, e70058. https:\/\/doi.org\/10.1371\/journal.pone.0070058 (2013).","journal-title":"PLoS ONE"},{"key":"41470_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/0975-1483.66805","volume":"2","author":"N Ali","year":"2010","unstructured":"Ali, N. & Shah, S. Spasmolytic activity of fruits of Tamarindus indica L. J. Young Pharm. 2, 261\u2013264. https:\/\/doi.org\/10.4103\/0975-1483.66805 (2010).","journal-title":"J. Young Pharm."},{"key":"41470_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.12980\/APJTB.4.2014APJTB-2014-0173","volume":"4","author":"P Kuru","year":"2014","unstructured":"Kuru, P. Tamarindus indica and its health related effects. Asian Pac. J. Trop. Biomed. 4, 676\u2013681. https:\/\/doi.org\/10.12980\/APJTB.4.2014APJTB-2014-0173 (2014).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"41470_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1163\/2031356X-02301006","volume":"23","author":"E Caluw\u00e9","year":"2010","unstructured":"Caluw\u00e9, E., Halamou\u00e1, K. & Van Damme, P. Tamarindus indica L.\u2014A review of traditional uses, phytochemistry and pharmacology. Afrika Focus 23, 53\u201383. https:\/\/doi.org\/10.1163\/2031356X-02301006 (2010).","journal-title":"Afrika Focus"},{"key":"41470_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/368354a0","volume":"368","author":"J Vidgren","year":"1994","unstructured":"Vidgren, J., Svensson, L. A. & Liljas, A. Crystal structure of catechol O-methyltransferase. Nature 368, 354\u2013358. https:\/\/doi.org\/10.1038\/368354a0 (1994).","journal-title":"Nature"},{"key":"41470_CR39","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.1039\/C9FO01744E","volume":"10","author":"D Morales","year":"2019","unstructured":"Morales, D. et al. In vitro and in vivo testing of the hypocholesterolemic activity of ergosterol- and \u03b2-glucan-enriched extracts obtained from shiitake mushrooms (Lentinula edodes). Food Funct. 10, 7325\u20137332. https:\/\/doi.org\/10.1039\/C9FO01744E (2019).","journal-title":"Food Funct."},{"key":"41470_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35, 1067\u20131069. https:\/\/doi.org\/10.1093\/bioinformatics\/bty707 (2019).","journal-title":"Bioinformatics"},{"key":"41470_CR41","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim, S. et al. PubChem 2025 update. Nucleic Acids Res. 53, D1516\u2013D1525. https:\/\/doi.org\/10.1093\/nar\/gkae1059 (2025).","journal-title":"Nucleic Acids Res."},{"key":"41470_CR42","unstructured":"Yang, H., Sun, L., Li, W., Liu, G. & Tang, Y. ADMET SAR 3.0: Online ADMET Prediction Tool. (2023)."},{"key":"41470_CR43","doi-asserted-by":"publisher","unstructured":"Lindahl, E., Abraham, M. J., Hess, B. & van der Spoel, D. GROMACS 2020.1 Source code. https:\/\/doi.org\/10.5281\/zenodo.3685919 (2020).","DOI":"10.5281\/zenodo.3685919"},{"key":"41470_CR44","unstructured":"Grace. <https:\/\/plasma-gate.weizmann.ac.il\/Grace\/> (1991)."},{"key":"41470_CR45","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s\u2011Tresanco","year":"2021","unstructured":"Vald\u00e9s\u2011Tresanco, M. S., Vald\u00e9s\u2011Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: A new tool to perform end\u2011state free energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"41470_CR46","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R. & Lynn, A. M. g_mmpbsa\u2013 A GROMACS tool for high\u2011throughput MM\u2011PBSA calculations. J. Chem. Inf. Model. 54, 1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"41470_CR47","doi-asserted-by":"publisher","unstructured":"Gewers, F. L. et al. Principal component analysis: A natural approach to data exploration. 54, Article 70, https:\/\/doi.org\/10.1145\/3447755 (2021).","DOI":"10.1145\/3447755"},{"key":"41470_CR48","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2015.0202","volume":"374","author":"IT Jolliffe","year":"2016","unstructured":"Jolliffe, I. T. & Cadima, J. Principal component analysis: A review and recent developments. Philos. Trans. R. Soc. A Math. Phys. Eng. Sci. 374, 20150202. https:\/\/doi.org\/10.1098\/rsta.2015.0202 (2016).","journal-title":"Philos. Trans. R. Soc. A Math. Phys. Eng. Sci."},{"key":"41470_CR49","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1080\/07391102.2019.1699446","volume":"38","author":"H Govindasamy","year":"2020","unstructured":"Govindasamy, H., Magudeeswaran, S. & Poomani, K. Identification of novel flavonoid inhibitor of Catechol-O-Methyltransferase enzyme by molecular screening, quantum mechanics\/molecular mechanics and molecular dynamics simulations. J. Biomol. Struct. Dyn. 38, 5307\u20135319. https:\/\/doi.org\/10.1080\/07391102.2019.1699446 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"41470_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161868","volume":"11","author":"N Patra","year":"2016","unstructured":"Patra, N., Ioannidis, E. I. & Kulik, H. J. Computational investigation of the interplay of substrate positioning and reactivity in Catechol O-Methyltransferase. PLoS ONE 11, e0161868. https:\/\/doi.org\/10.1371\/journal.pone.0161868 (2016).","journal-title":"PLoS ONE"},{"key":"41470_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/ml500502d","volume":"6","author":"ST Harrison","year":"2015","unstructured":"Harrison, S. T. et al. Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of Catechol-O-methyltransferase (COMT). ACS Med. Chem. Lett. 6, 318\u2013323. https:\/\/doi.org\/10.1021\/ml500502d (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"41470_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092816","author":"JCJ Bergin","year":"2022","unstructured":"Bergin, J. C. J. et al. 1-Hydroxy-2(1H)-pyridinone-based chelators with potential catechol O-methyl transferase inhibition and neurorescue dual action against Parkinson\u2019s disease. Molecules https:\/\/doi.org\/10.3390\/molecules27092816 (2022).","journal-title":"Molecules"},{"key":"41470_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12111995","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Plant-wide target metabolomics provides a novel interpretation of the changes in chemical components during Dendrobium officinale traditional processing. Antioxidants (Basel) https:\/\/doi.org\/10.3390\/antiox12111995 (2023).","journal-title":"Antioxidants (Basel)"},{"key":"41470_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051561","author":"L Swiatek","year":"2023","unstructured":"Swiatek, L. et al. Herb Robert\u2019s gift against human diseases: Anticancer and antimicrobial activity of Geranium robertianum L.. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15051561 (2023).","journal-title":"Pharmaceutics"},{"key":"41470_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093144","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Tyrosinase-targeting gallacetophenone inhibits melanogenesis in melanocytes and human skin-equivalents. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21093144 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"41470_CR56","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.5958\/0974-360X.2020.00714.3","volume":"13","author":"MI Narwanto","year":"2020","unstructured":"Narwanto, M. I., Rahayu, M., Soeharto, S., Nurdiana, N. & Widodo, M. A. Neuroprotective potency of Tamarindus indica seed extract for preventing memory impairment in rat model of Alzheimer\u2019s Disease. Res. J. Pharm. Technol. 13, 4041\u20134046. https:\/\/doi.org\/10.5958\/0974-360X.2020.00714.3 (2020).","journal-title":"Res. J. Pharm. Technol."},{"key":"41470_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.imr.2019.07.002","volume":"8","author":"R Komakech","year":"2019","unstructured":"Komakech, R., Kim, Y. G., Matsabisa, G. M. & Kang, Y. Anti-inflammatory and analgesic potential of Tamarindus indica Linn. (Fabaceae): A narrative review. Integr Med Res 8, 181\u2013186. https:\/\/doi.org\/10.1016\/j.imr.2019.07.002 (2019).","journal-title":"Integr Med Res"},{"key":"41470_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2019.00916","volume":"10","author":"Y Lima-Melo","year":"2019","unstructured":"Lima-Melo, Y. et al. Photoinhibition of Photosystem I provides oxidative protection during imbalanced photosynthetic electron transport in Arabidopsis thaliana. Front. Plant Sci. 10, 916. https:\/\/doi.org\/10.3389\/fpls.2019.00916 (2019).","journal-title":"Front. Plant Sci."},{"key":"41470_CR59","doi-asserted-by":"publisher","unstructured":"Dhanani, T., Shah, S., Gajbhiye, N. A. & Kumar, S. Effect of extraction methods on yield, phytochemical constituents and antioxidant activity of Withania somnifera. Arab. J. Chem. (in press). https:\/\/doi.org\/10.1016\/j.arabjc.2013.02.015 (2013).","DOI":"10.1016\/j.arabjc.2013.02.015"},{"key":"41470_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092834","author":"C Gnanaraj","year":"2022","unstructured":"Gnanaraj, C. et al. In silico molecular docking analysis of Karanjin against Alzheimer\u2019s and Parkinson\u2019s diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules https:\/\/doi.org\/10.3390\/molecules27092834 (2022).","journal-title":"Molecules"},{"key":"41470_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/1871524919666190619090852","volume":"19","author":"I Engelbrecht","year":"2019","unstructured":"Engelbrecht, I., Petzer, J. P. & Petzer, A. Evaluation of selected natural compounds as dual inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase. Cent. Nerv. Syst. Agents Med. Chem. 19, 133\u2013145. https:\/\/doi.org\/10.2174\/1871524919666190619090852 (2019).","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"41470_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00044-015-1472-z","volume":"25","author":"MK Mazumder","year":"2015","unstructured":"Mazumder, M. K., Bhattacharjee, N. & Borah, A. Garcinol prevents hyperhomocysteinemia and enhances bioavailability of L\u2011DOPA by inhibiting catechol\u2011O\u2011methyltransferase: An in silico approach. Med. Chem. Res. 25, 116\u2013122. https:\/\/doi.org\/10.1007\/s00044-015-1472-z (2015).","journal-title":"Med. Chem. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41470-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:16:44Z","timestamp":1778581004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41470-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41470"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41470-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14227"}}